Patients With Amyloidosis Undergoing Transcatheter Edge-to-edge Repair Have Greater Risk Of Mortality And Higher Resource Utilization, Nation-wide Study

Leonid Khokhlov,Fatima Hussain,Mehnaaz Ali,Angel Mena,Amr Aboelnasr,Sila Mateo-Faxas,Amin Eshghabadi,Mohamad Hijazi,Kenan Rahima,Sindhu Kishore,Kamal Shemisa,Mohammed Al-Amoodi

DOI: https://doi.org/10.1016/j.cardfail.2023.10.174

IF: 6.592

2024-01-01

Journal of Cardiac Failure

Abstract:Background Transcatheter edge-to-edge repair (TEER) is a minimally invasive approach in the treatment of primary mitral regurgitation. Amyloidosis is a rare condition caused by misfolded protein fibrils deposition in the extracellular space. There is limited evidence of clinical outcomes in patients hospitalized for TEER and affected by amyloidosis. Hence, we sought to investigate this population. Methods We queried NIS between 2017-2020 for adult patients hospitalized for TEER with concomitant amyloidosis (codes for organ-specific, light-chain and transthyretin amyloidosis were used). The primary outcome was inpatient mortality. The secondary outcomes were cardiogenic shock, length of stay (LOS) and total hospital charge. Multivariable logistic and Poisson regression analyses were used to estimate clinical outcomes. P-value < 0.05 was significant. Results There were 34,765 ACS hospitalizations and 40 (0.2%) had amyloidosis. Amyloidosis and non-amyloidosis cohorts were with mean age of 72.3 vs 77 yrs; males 75% vs 54.3%; Caucasians 87.5% vs 77.0%; HTN 25% vs 9.8%; HF 100% vs 85.4%; HFrEF 50% vs 44.2%; pulmonary hypertension (PH) 50% vs 27.8%; DM 25% vs 28.2%; AF 62.5% vs 60.4%; CKD 62.5% vs 40.6%; AKI 25% vs 15.7%; GIB 12.5% vs 1.5%; obesity 37.5% vs 11.2%; ACS 12.5% vs 2.9%; PPM insertion 12.5% vs 0.5%; history of MI 12.5% vs 16%; respectively. Amyloidosis cohort had tendency to greater mortality and higher resource utilization (Table 1). Conclusion Amyloidosis group demonstrated tendency to higher mortality, cardiogenic shock, and resource utilization. Patients were younger, male, white, with more prevalent HTN, HF (including HFrEF), PH, AF, CKD, AKI, GIB, obesity, ACS, and PPM implantation. Amyloidosis is associated with cardiopulmonary insufficiency, renal impairment, and adverse events. Early identification of amyloidosis in patients undergoing TEER might be beneficial in terms of risk stratification and prognostication. Further research is necessary to describe long-term outcomes in this population.

cardiac & cardiovascular systems